SMAD4 and non-small cell lung carcinoma: Combined with our research and existing reports, we believe that the reduction of serum Smad4 concentration is related to the occurrence and development of NSCLC and Smad4 may be a potential target for clinical diagnosis and treatment of NSCLC.